Literature DB >> 10898901

No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.

E Tahir1, S Curran, Y Yazgan, F Ozbay, B Cirakoglu, P J Asherson.   

Abstract

Biochemical and genetic studies of attention deficit hyperactivity disorder (ADHD) suggest that regulation of catecholamine neurotransmission is a key factor in the aetiology of the disorder. In particular, it is postulated that an underactive dopamine system is associated with the disorder. In this study we have tested this hypothesis by screening a clinical sample of Turkish children with the combined subtype of ADHD with a functional variant of catecholamine-methyl-transferase (COMT) that codes for high- and low-activity variants of the enzyme. Using within-family tests of association and linkage in a sample of 72 children, we found no evidence for a genetic association or linkage. We conclude that altered regulation of catecholamines due to this polymorphism does not have a significant main effect on the risk for ADHD in this population. However, it remains feasible that more minor effects or interacting effects with other genes or environment exist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898901     DOI: 10.1002/1096-8628(20000612)96:3<285::aid-ajmg10>3.0.co;2-d

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.

Authors:  Mark A Bellgrove; Katharina Domschke; Ziarih Hawi; Aiveen Kirley; Celine Mullins; Ian H Robertson; Michael Gill
Journal:  Exp Brain Res       Date:  2005-01-15       Impact factor: 1.972

Review 2.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

3.  Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant.

Authors:  Haukur Pálmason; Dirk Moser; Jessica Sigmund; Christian Vogler; Susann Hänig; Anna Schneider; Christiane Seitz; Alexander Marcus; Jobst Meyer; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2009-11-28       Impact factor: 3.575

4.  COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.

Authors:  Sarojini Sengupta; Natalie Grizenko; Norbert Schmitz; George Schwartz; Johanne Bellingham; Anna Polotskaia; Marina Ter Stepanian; Yukiori Goto; Anthony A Grace; Ridha Joober
Journal:  Neuropsychopharmacology       Date:  2008-06-25       Impact factor: 7.853

Review 5.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

6.  Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases.

Authors:  Dilek Unal; Mehmet Fatih Unal; Mehmet Alikasifoglu; Arda Cetinkaya
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505

7.  No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study.

Authors:  Sophie Mills; Kate Langley; Marianne Van den Bree; Eddy Street; Darko Turic; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  BMC Psychiatry       Date:  2004-06-07       Impact factor: 3.630

8.  The Effect of Single Dose Methylphenidate on Neurometabolites according to COMT Gene Val158Met Polymorphism in the Patient with Attention Deficit Hyperactivity Disorder: A Study Using Magnetic Resonance Spectroscopy.

Authors:  Onder Ozturk; Huseyin Alacam; Burge Kabukcu Basay; Omer Basay; Ahmet Buber; Ozlem Izci Ay; Kadir Agladıoglu; Mehmet Emin Erdal; Hasan Herken
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.